Torres-Quesada Omar, Doerrier Carolina, Strich Sophie, Gnaiger Erich, Stefan Eduard
Tyrolean Cancer Research Institute (TKFI), Innrain 66, 6020 Innsbruck, Austria.
Institute of Biochemistry and Center for Molecular Biosciences, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.
Cancers (Basel). 2022 Aug 13;14(16):3917. doi: 10.3390/cancers14163917.
Two-dimensional cell cultures are established models in research for studying and perturbing cell-type specific functions. However, many limitations apply to the cell growth in a monolayer using standard cell culture media. Although they have been used for decades, their formulations do not mimic the composition of the human cell environment. In this study, we analyzed the impact of a newly formulated human plasma-like media (HPLM) on cell proliferation, mitochondrial bioenergetics, and alterations of drug efficacies using three distinct cancer cell lines. Using high-resolution respirometry, we observed that cells grown in HPLM displayed significantly altered mitochondrial bioenergetic profiles, particularly related to mitochondrial density and mild uncoupling of respiration. Furthermore, in contrast to standard media, the growth of cells in HPLM unveiled mitochondrial dysfunction upon exposure to the FDA-approved kinase inhibitor sunitinib. This seemingly context-dependent side effect of this drug highlights that the selection of the cell culture medium influences the assessment of cancer drug sensitivities. Thus, we suggest to prioritize media with a more physiological composition for analyzing bioenergetic profiles and to take it into account for assigning drug efficacies in the cell culture model of choice.
二维细胞培养是研究和干扰细胞类型特异性功能的成熟研究模型。然而,使用标准细胞培养基在单层中进行细胞生长存在许多局限性。尽管它们已经被使用了几十年,但其配方并不能模拟人类细胞环境的组成。在本研究中,我们使用三种不同的癌细胞系分析了新配制的类人血浆培养基(HPLM)对细胞增殖、线粒体生物能量学以及药物疗效改变的影响。通过高分辨率呼吸测定法,我们观察到在HPLM中生长的细胞显示出线粒体生物能量学特征显著改变,特别是与线粒体密度和呼吸的轻度解偶联有关。此外,与标准培养基相比,在HPLM中细胞生长在暴露于FDA批准的激酶抑制剂舒尼替尼后显示出线粒体功能障碍。这种药物看似依赖于环境的副作用突出表明,细胞培养基的选择会影响癌症药物敏感性的评估。因此,我们建议优先选择具有更生理组成的培养基来分析生物能量学特征,并在所选的细胞培养模型中考虑其对药物疗效的影响来确定药物疗效。